000 | 01707 a2200469 4500 | ||
---|---|---|---|
005 | 20250516203054.0 | ||
264 | 0 | _c20150109 | |
008 | 201501s 0 0 eng d | ||
022 | _a1873-7064 | ||
024 | 7 |
_a10.1016/j.neuropharm.2014.03.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKoshy Cherian, Ajeesh | |
245 | 0 | 0 |
_aA systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. _h[electronic resource] |
260 |
_bNeuropharmacology _cJul 2014 |
||
300 |
_a41-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCentral Nervous System Agents _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
650 | 0 | 4 |
_aKynurenic Acid _xmetabolism |
650 | 0 | 4 |
_aKynurenine _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 | _aMicrodialysis |
650 | 0 | 4 | _aMicroelectrodes |
650 | 0 | 4 |
_aNicotine _xpharmacology |
650 | 0 | 4 |
_aNicotinic Agonists _xpharmacology |
650 | 0 | 4 |
_aPotassium Chloride _xpharmacology |
650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aTransaminases _xantagonists & inhibitors |
700 | 1 | _aGritton, Howard | |
700 | 1 | _aJohnson, David E | |
700 | 1 | _aYoung, Damon | |
700 | 1 | _aKozak, Rouba | |
700 | 1 | _aSarter, Martin | |
773 | 0 |
_tNeuropharmacology _gvol. 82 _gp. 41-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2014.03.004 _zAvailable from publisher's website |
999 |
_c23656303 _d23656303 |